Stay updated on Dapagliflozin in Acute Heart Failure Clinical Trial

Sign up to get notified when there's something new on the Dapagliflozin in Acute Heart Failure Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Dapagliflozin in Acute Heart Failure Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The page now renders a 403 Forbidden error page, replacing the previous study record content and navigation. This indicates access is blocked rather than displaying the study details.
    Difference
    18%
    Check dated 2026-09-21T21:01:26.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    30 days ago
    Change Detected
    Summary
    A new publication citation from JACC Heart Fail about in-hospital initiation of dapagliflozin was added, and the page revision was updated to v3.6.6.
    Difference
    0.1%
    Check dated 2026-08-31T16:27:19.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    Revision updated from v3.6.4 to v3.6.5 on the page, indicating a small metadata update to the ClinicalTrials.gov entry rather than a change to study details.
    Difference
    0.1%
    Check dated 2026-08-10T02:07:17.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.3 to v3.6.4, indicating a new build of the page. This is a deployment update and does not appear to alter the study details or how the page is used.
    Difference
    0.1%
    Check dated 2026-07-26T14:33:33.000Z thumbnail image
  7. Check
    87 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.3, indicating a new UI/version tag and replacing the previous Revision: v3.6.2. This update appears to be a behind-the-scenes platform change rather than a modification to study content.
    Difference
    0.1%
    Check dated 2026-07-05T04:29:36.000Z thumbnail image
  8. Check
    95 days ago
    Change Detected
    Summary
    Added the Results section with detailed primary and secondary outcomes, including the composite CV death or worsening heart failure and the hierarchical win-ratio endpoint. The entry also includes Results First Posted dates and links to related publications and the study protocol.
    Difference
    3%
    Check dated 2026-06-27T23:27:14.000Z thumbnail image

Stay in the know with updates to Dapagliflozin in Acute Heart Failure Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Dapagliflozin in Acute Heart Failure Clinical Trial page.